Loading
A small GRAIL pilot that checks whether the medical records of people who had the Galleri test can be collected accurately, ahead of a larger follow-up study.
Galleri Community Research Program (NCT06603259) is an observational study sponsored by GRAIL, Inc. Its primary outcome is the quality of data retrieved from participants who have had the Galleri test.
The registry record, read on 29 October 2026, gives its status as unknown (the sponsor last updated it on 19 September 2024), with an estimated 250 participants, a start on 19 August 2024 and primary completion expected in December 2025.
Shares GRAIL, Galleri, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares GRAIL, Galleri, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares GRAIL, Galleri, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares GRAIL, Galleri, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares GRAIL, Galleri, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares GRAIL, Galleri, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares GRAIL, Galleri, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares GRAIL, Galleri, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/